公开(公告)号：US20190055506A1

公开(公告)日：2019-02-21

申请号：US15573381

申请日：2016-05-11

申请人： XIAMEN UNIVERSITY ,  XIAMEN INNODX BIOTECH CO., LTD

发明人： Shengxiang GE ,  Shiyin ZHANG ,  Feihai XU ,  Jin WANG ,  Jinjie LI ,  Jun ZHANG ,  Ningshao XIA

IPC分类号： C12M1/38 ,  C12M1/24 ,  C12Q1/6844 ,  B01L3/00

摘要： Disclosed are a reaction tube for nucleic acid amplification capable of controlling a liquid circulation path, a reaction apparatus for nucleic acid amplification comprising the reaction tube, and a method for amplifying nucleic acid comprising a step of using the reaction tube. Also disclosed are a kit comprising the reaction tube, and use of the reaction tube in preparation of a kit.

公开(公告)号：US20180031556A1

公开(公告)日：2018-02-01

申请号：US15549443

申请日：2016-01-26

申请人： XIAMEN UNIVERSITY

发明人： Shengxiang GE ,  Jinjie LI ,  Xi HUANG ,  Tingdong LI ,  Jun ZHANG ,  Ningshao XIA

IPC分类号： G01N33/569

CPC分类号： G01N33/56983 ,  G01N33/53 ,  G01N33/543 ,  G01N33/569 ,  G01N33/56994 ,  G01N2333/045 ,  G01N2469/20 ,  G01N2800/50 ,  G01N2800/52

摘要： The invention belongs to the fields of medicine and immunology, particularly, the field of immunological diagnosis. In particular, the invention discloses a method for assessing whether a subject is at risk of developing human cytomegalovirus (HCMV) active infection and a kit therefore. The method comprises the steps of: (1) determining the level of an antibody against a HCMV protein in a body fluid sample from the subject; and (2) comparing the level with a predetermined reference value, wherein if the level is below the predetermined reference value, the subject is determined to be at risk of developing HCMV active infection. In addition, the invention also discloses a method for screening a candidate drug which is capable of improving the ability of a subject to resist human cytomegalovirus (HCMV) active infection, and a kit therefore.